Product
Osimertinib Mesylate
Aliases
AZD9291
2 clinical trials
2 indications
Indication
Healthy Control ParticipantsClinical trial
Studies to Compare the Pharmacokinetics of TY-9591 Tablets and Osimertinib Mesylate Tablets After a Single Fasting Administration and Determine the Effect of Food on the Pharmacokinetics of TY-9591 Tablets in Healthy VolunteersStatus: Completed, Estimated PCD: 2021-09-09
Clinical trial
A Phase Ib Study of Safety and Efficacy of APG-1252 in Combination With Osimertinib (AZD9291) in EGFR TKI Resistant NSCLC PatientsStatus: Recruiting, Estimated PCD: 2024-12-01